Medical marijuana might help MS patients, but uncertainty remains

October 13, 2018 by Dennis Thompson, Healthday Reporter

Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients.

Drugs containing the major chemical compounds in cannabis are associated with a limited and mild reduction in muscle contractions, bladder dysfunction and pain, based on patient self-assessments from included in a major new evidence review.

"The bottom line is there is certainly something happening with cannabinoids in regard to symptoms," said Nicholas LaRocca, vice president of healthcare delivery and policy research at the National Multiple Sclerosis Society.

However, patients' self-reports of benefits related to muscle contractions differed from results of objective scales used by doctors, LaRocca noted. The doctors observed no such benefit from marijuana medications.

"That's something that's obviously a concern," LaRocca said.

The clinical trials also showed that cannabis-derived drugs come with few side effects and no serious ones, noted Dr. Marissa Slaven, an assistant professor of palliative care at McMaster University in Hamilton, Ontario, Canada.

"It definitely adds to the literature in suggesting this is a safe treatment," said Slaven, who wrote an editorial accompanying the new evidence review. "Whether or not it's effective, I think we need more research."

The evidence review, conducted by Mari Carmen Torres-Moreno, of the University of Barcelona in Spain and colleagues, included clinical trials related to four cannabis-derived preparations: orally administered cannabis extract, nasally administered cannabis extract, and the drugs dronabinol and nabilone.

Dronabinol and nabilone are both synthetic versions of THC, the chemical in marijuana that causes intoxication. Both are used to treat nausea and vomiting caused by chemotherapy.

The new evidence review combined 17 clinical trials involving 3,161 patients. Researchers concluded from the review that cannabis-derived drugs can be considered safe and have limited effectiveness in treating MS symptoms.

Side effects associated with the drugs included dizziness, dry mouth, fatigue, intoxication, impaired balance, memory problems and sleepiness. But these did not lead to a statistically significant number of people dropping out of the trials.

"There was a very slightly positive effect that was seen as a statistical positive, but whether that is something that would bear out clinically is difficult to say," Slaven said.

The upshot of the review is that more research is needed to nail down medical marijuana's ability to help people with , LaRocca and Slaven agreed. MS is a progressive and degenerative disease in which the immune system attacks nerves, producing a variety of neurological symptoms.

"In spite of very strong interest in cannabinoid therapy, we really have relatively little in terms of good research to guide us in terms of what does and what doesn't work, what works for which types of individuals, and so forth," LaRocca said.

Because of the lack of evidence, practitioners tend to recommend other established therapies for MS over marijuana-derived drugs, he added.

"There's really relatively little data that's strong. I think that discourages practitioners from feeling comfortable about recommending this, because there just isn't as much data out there," LaRocca explained.

Research on has been hampered in the United States due to restrictions based on federal law, LaRocca said.

There had been hope that marijuana growers and processors might fund medical research to better establish the effectiveness of their products, but the wave of legalizing recreational use might have put a damper on that, Slaven said.

"I fear with legalization of recreational marijuana the companies may make a lot of money that way and will have no incentive to invest in medical research," she said.

Slaven added that none of these trials involved smoked marijuana. They instead focused on cannabis extracts and man-made versions of THC. The cannabis extracts also included cannabidiol, a chemical compound in that is not intoxicating but could have some medical benefit.

"We know there are many, many different cannabis products available, but we don't know which components are the most important and the most effective at this time," Slaven said.

The new evidence review was published online Oct. 12 in JAMA Network Open.

Explore further: Q&A: Treatment with medical cannabis

More information: JAMA Network Open, online. … etworkopen.2018.3485

The National Multiple Sclerosis Society has more about medical marijuana and MS.

Related Stories

Q&A: Treatment with medical cannabis

September 27, 2018
Dear Mayo Clinic: Medical marijuana is now legal in the state where I live. What conditions can it be used for and how effective is it? Do people who use medical marijuana need to be concerned about addiction?

Coca-Cola looking at cannabis-infused drinks

September 17, 2018
Coca-Cola said Monday it is studying the use of a key ingredient in marijuana in "wellness beverages," as a growing number of mainstream companies develop cannabis-infused drinks.

Can medical marijuana help treat intractable epilepsy?

August 8, 2018
A new British Journal of Clinical Pharmacology review examines the potential of medicinal cannabis—or medical marijuana—for helping patients with intractable epilepsy, in which seizures fail to come under control with ...

Jefferson University offers medical marijuana grad programs

July 13, 2018
Thomas Jefferson University in Philadelphia will be offering graduate-level certificate programs in medical marijuana.

New guideline warns pain benefits of medical cannabis overstated

February 15, 2018
A new medical guideline published today suggests Canada's family physicians should take a sober second thought before prescribing medical cannabis to most patients.

Component of marijuana may help treat anxiety and substance abuse disorders

March 8, 2017
Cannabidiol, a major component of cannabis or marijuana, appears to have effects on emotion and emotional memory, which could be helpful for treating anxiety-related and substance abuse disorders.

Recommended for you

A versatile vaccine that can protect mice from emerging tick-borne viruses

December 18, 2018
A group of researchers led by Michael Diamond of Washington University School of Medicine in St. Louis have developed a vaccine that is effective in mice against Powassan virus, an emerging tick-borne virus that can cause ...

How cholera bacteria make people so sick

December 18, 2018
The enormous adaptability of the cholera bacterium explains why it is able to claim so many victims. Professor Ariane Briegel from the Leiden Institute of Biology has now discovered that this adaptability is due to rapid ...

Green leafy vegetables may prevent liver steatosis

December 17, 2018
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake ...

Discovery of novel mechanisms that cause migraines

December 17, 2018
Researchers at CNRS, Université Côte d'Azur and Inserm have demonstrated a new mechanism related to the onset of migraine. They found how a mutation that causes dysfunction in a protein which inhibits neuronal electrical ...

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...


Adjust slider to filter visible comments by rank

Display comments: newest first

1 / 5 (1) Oct 13, 2018
give 'em all they want and see what happens.
not rated yet Oct 13, 2018
Drug Test? LOL

Spaced out Engineer
1 / 5 (1) Oct 13, 2018
give 'em all they want and see what happens.

The won't. The FDA and Fushion centers can use such information to "weed out" the local demograph.
Empowered is anyone who has enough followers on twitter and minor offenses are enough to justify covert murder.
1 / 5 (2) Oct 13, 2018
Aw shucks, we don't need studies, weed is good for everything, next it will be in cereal and everything else you eat except meat 'cause potheads don't do meat
3.7 / 5 (3) Oct 14, 2018

No bias there, . . .

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.